<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5102</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26696825</article-id>
<article-id pub-id-type="pmc">4677093</article-id>
<article-id pub-id-type="doi">10.3389/fncel.2015.00465</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Perspective</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>A Perspective on the Role of microRNA-128 Regulation in Mental and Behavioral Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ching</surname>
<given-names>Ai-Sze</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/242618/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ahmad-Annuar</surname>
<given-names>Azlina</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/242310/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff>
<institution>Department of Biomedical Science, Faculty of Medicine, University of Malaya</institution>
<country>Kuala Lumpur, Malaysia</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: <italic>Antonio Gambardella, Magna Græcia University of Catanzaro, Italy</italic></p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: <italic>Vincenzo De Paola, Imperial College London, UK; Paola Tognini, University of California, Irvine, USA; Viola Nordström, German Cancer Research Center and Heidelberg University, Germany</italic></p>
</fn>
<corresp id="fn001">*Correspondence: <italic>Azlina Ahmad-Annuar, <email xlink:type="simple">azlina_aa@um.edu.my</email></italic></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>12</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>9</volume>
<elocation-id>465</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>6</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>11</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2015 Ching and Ahmad-Annuar.</copyright-statement>
<copyright-year>2015</copyright-year>
<copyright-holder>Ching and Ahmad-Annuar</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>MiRNAs are short, non-coding RNA molecules that regulate gene expression post-transcriptionally. Over the past decade, misregulated miRNA pathways have been associated with various diseases such as cancer, neurodegenerative diseases, and neurodevelopmental disorders. In this article, we aim to discuss the role played by <italic>miR-128</italic> in neuropsychiatric disorders, and highlight potential target genes from an <italic>in silico</italic> analysis of predicted <italic>miR-128</italic> targets. We also discuss the differences of target gene determination based on a bioinformatics or empirical approach. Using data from TargetScan and published reports, we narrowed the <italic>miR-128</italic> target gene list to those that are known to be associated with neuropsychiatric disorders, and found that these genes can be classified into 29 gene clusters and are mostly enriched in cancer and MAPK signaling pathways. We also highlight some recent studies on several of the <italic>miR-128</italic> targets which should be investigated further as potential candidate genes for therapeutic interventions.</p>
</abstract>
<kwd-group>
<kwd>microRNAs</kwd>
<kwd>gene expression</kwd>
<kwd>neuropsychiatric disorders</kwd>
<kwd>anxiety</kwd>
<kwd>fear</kwd>
<kwd>movement disorders</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Ministry of Higher Education, Malaysia<named-content content-type="fundref-id">10.13039/501100003093</named-content></funding-source>
<award-id rid="cn001">MOHE-HIR-E29</award-id>
</award-group>
<award-group>
<funding-source id="cn002">Universiti Malaya<named-content content-type="fundref-id">10.13039/501100004386</named-content></funding-source>
<award-id rid="cn002">RG399/12HTM</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="81"></ref-count>
<page-count count="8"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>Mature microRNAs (miRNAs) are endogenous, small (approximately 22 nucleotides long), non-coding RNA molecules which regulate their target genes post-transcriptionally by targeting the 3′ untranslated region (UTR), 5′UTR and coding regions of target messenger RNAs (mRNAs) thus causing translational repression or mRNA degradation (<xref ref-type="bibr" rid="B41">Lewis et al., 2005</xref>; <xref ref-type="bibr" rid="B4">Bartel, 2009</xref>; <xref ref-type="bibr" rid="B39">Lee et al., 2009</xref>; <xref ref-type="bibr" rid="B63">Schmiedel et al., 2015</xref>).</p>
<p>MicroRNA-128 (<italic>miR-128</italic>) is an intronic miRNA and the mature <italic>miR-128</italic> form is encoded by the two isoforms; <italic>miR-128-1</italic> and <italic>miR-128-2</italic> (<xref ref-type="bibr" rid="B47">Megraw et al., 2010</xref>). The <italic>pri-miR-128-1</italic> gene resides within the R3H domain containing protein 1 gene (<italic>R3HDM1</italic>) and <italic>pri-miR-128-2</italic> lies within the cAMP-regulated phosphoprotein, 21 kDa gene (<italic>ARPP21</italic>, also known as regulator of calmodulin signaling, <italic>RCS</italic>). This organization is conserved in human, rat and mouse genomes.</p>
<p>Early studies on <italic>miR-128</italic> pointed to its tumor suppressive activity. Loss of <italic>MIR-128</italic> was reported in human lung cancers – due to a deletion in chromosome 3p which included the <italic>MIR-128-2</italic> and <italic>ARPP21</italic> locus (<xref ref-type="bibr" rid="B74">Weiss et al., 2008</xref>) and in breast cancer (<xref ref-type="bibr" rid="B59">Qian et al., 2012</xref>).</p>
<p>Apart from its anti-cancer activity, <italic>miR-128</italic> is of particular interest to neuroscientists as it is a brain-enriched miRNA which is highly expressed in the cortex and cerebellum, with distinct patterns of expression in developing brains and maturing cortical neurons (<xref ref-type="bibr" rid="B34">Krichevsky et al., 2003</xref>; <xref ref-type="bibr" rid="B30">Kim et al., 2004</xref>; <xref ref-type="bibr" rid="B65">Smirnova et al., 2005</xref>). Overexpression of <italic>miR-128</italic> promotes neuronal differentiation in P19 cells and in primary embryonic neural stem cells through the suppression of non-sense-mediated decay (<xref ref-type="bibr" rid="B7">Bruno et al., 2011</xref>; <xref ref-type="bibr" rid="B29">Karam and Wilkinson, 2012</xref>). <italic>MiR-128</italic>- transduced human induced pluripotent stem cells shows similar characteristics as mature neurons and enhances the expression of beta-tubulin and other neuronal markers (<xref ref-type="bibr" rid="B79">Zare et al., 2015</xref>).</p>
<p>Recent studies have begun to relate <italic>MIR-128</italic> and <italic>ARPP21</italic> with neuropsychiatric disorders such as fear response, anxiety, intellectual disability and in movement disorders (<xref ref-type="bibr" rid="B43">Lin et al., 2011</xref>; <xref ref-type="bibr" rid="B13">Davis et al., 2012</xref>; <xref ref-type="bibr" rid="B46">Marangi et al., 2013</xref>;<xref ref-type="bibr" rid="B68">Tan et al., 2013</xref>). <xref ref-type="bibr" rid="B68">Tan et al. (2013)</xref> observed early onset fatal epilepsy and increased neuronal activity in mice with <italic>miR-128</italic> deficiency. In this study, dopamine-1 receptor neurons with suppressed <italic>miR-128</italic> expression showed enhanced dendritic excitability and increased dendritic spine formation. Recently, a family with a deletion of the <italic>MIR-128-2</italic> and <italic>ARPP21</italic> locus (chromosome 3p22.3p22.2) was reported to present with intellectual disability and epileptic episodes (<xref ref-type="bibr" rid="B46">Marangi et al., 2013</xref>). Several family members also had two other chromosomal abnormalities (3p24.3 deletion and 6p22.31 duplication), and suffered from febrile seizures during early childhood and decreased muscle tone. However, no direct link to <italic>ARPP21</italic> or <italic>MIR-128</italic> was discussed in the paper. It is interesting to note that a deletion in the same locus can also give rise to lung cancer, mentioned above (<xref ref-type="bibr" rid="B74">Weiss et al., 2008</xref>). The actual phenotype that manifests may be subject to environmental factors or other uncharacterised genetic factors.</p>
<p>Further evidence of the key role of <italic>MIR-128</italic> in cognitive function comes from studies where mice were trained on a fear-conditioning paradigm, and the level of <italic>miR-128</italic> expression was observed to increase upon learning the associated tasks (<xref ref-type="bibr" rid="B43">Lin et al., 2011</xref>). Interestingly, knockout <italic>Arpp21/Rcs</italic> mice showed anxiety-like behavior and had decreased motivation in food-rewarded tasks (<xref ref-type="bibr" rid="B13">Davis et al., 2012</xref>). However, in these papers there is no data to directly link <italic>miR-128</italic> to these phenotypes and it may be that the abnormalities seen could involve other pathways, perhaps through <italic>Arpp21/Rcs</italic> direct interaction with calmodulin.</p>
<p>Several lines of evidence point to <italic>miR-128</italic> and <italic>Arpp21</italic> being susceptible to pharmacological modulation in relation to schizophrenia and depression. Rats administered with the antipsychotic drug, haloperidol, exhibited an increase in the expression of <italic>miR-128</italic> in the prefrontal cortex, but no differences were seen in human schizophrenic patients when compared to controls (<xref ref-type="bibr" rid="B57">Perkins et al., 2007</xref>). <italic>MIR-128-1</italic> overexpression has been also reported in the dorsolateral prefrontal cortices of schizophrenic patients (<xref ref-type="bibr" rid="B5">Beveridge et al., 2010</xref>) and patients with major depression treated with selective serotonin reuptake inhibitor antidepressant treatments, showed an upregulation of <italic>MIR-128</italic> in their blood (<xref ref-type="bibr" rid="B6">Bocchio-Chiavetto et al., 2013</xref>). However, these studies do not conclusively show that the <italic>MIR-128</italic> upregulation was due to the psychiatric disorders alone, or whether the elevation was in part due to the drug treatment.</p>
<p>Given that there is mounting evidence that <italic>MIR-128</italic> is important in neuropsychiatric/ neurological disorders, and the recent <xref ref-type="bibr" rid="B68">Tan et al. (2013)</xref> report listing 1061 target genes of <italic>miR-128</italic>, we aimed to pull together results from numerous reports to determine what were the most likely candidate genes involved in this pathological process. We compared the target gene dataset from <xref ref-type="bibr" rid="B68">Tan et al. (2013)</xref> with datasets obtained through TargetScan analysis and searched the literature for reported target genes, to enable further exploration into their potential neuropsychiatric role. Using this approach, we narrowed down the list of potential target genes to 108. These genes can be classified into several functional clusters and share biological pathways that are relevant as possible therapeutic targets for neuropsychiatric disorders.</p>
</sec>
<sec>
<title><italic>In Silico</italic> Analysis For <italic>miR-128</italic> Target Genes</title>
<p>We performed a TargetScan analysis to determine the predicted target genes of <italic>miR-128</italic>. TargetScan (<ext-link ext-link-type="uri" xlink:href="http://www.targetscan.org">www.targetscan.org</ext-link>) is an online miRNA target site prediction database which selects possible target genes based on identifying the conserved 7-8mer miRNA sequences on the 3′UTR of these genes that are complementary with the miRNA seed region (<xref ref-type="bibr" rid="B41">Lewis et al., 2005</xref>). This analysis identified 801 genes as potential <italic>miR-128</italic> targets (TargetScan release 6.2, named as Data TS, <bold>Figure <xref ref-type="fig" rid="F1">1A</xref></bold>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p><bold>(A)</bold> The Venn diagram shows the number of <italic>miR-128</italic> target genes as identified by <xref ref-type="bibr" rid="B68">Tan et al. (2013)</xref> TargetScan and published targets. Total number of genes that are shared between <xref ref-type="bibr" rid="B68">Tan et al. (2013)</xref> and TargetScan is 214 genes; 34 genes are shared by TargetScan and our list of published <italic>miR-128</italic> targets. <bold>(B)</bold> Top 10 functional clusters of <italic>miR-128</italic> target genes as classified by DAVID bioinformatics tool. Using the mouse genome as the background, the threshold was set at the following criteria: classification stringency = highest; maximum EASE score = 0.05. EASE score is a modified Fisher Exact p value which range from 0 to 1, with 0 shows perfect enrichment. <bold>(C)</bold> Biological pathways (KEGG database) shared by <italic>miR-128</italic> target genes as annotated by the KEGG pathway database. Using the mouse genome as background, the threshold was set at the following criteria: minimum number of genes for the corresponding pathway = 2; maximum EASE score = 0.05.</p>
</caption>
<graphic xlink:href="fncel-09-00465-g001"></graphic>
</fig>
<p>We then used data from <xref ref-type="bibr" rid="B68">Tan et al. (2013)</xref> where a HITS-CLIP (high-throughput sequencing of RNA isolated by crosslinking immunoprecipitation) approach identified 1061 genes (Dataset T). This dataset was specific to genes which were in an RNA-induced silencing complex (RISC) with <italic>miR-128</italic> in adult <italic>Camk2a</italic>-neurons. <xref ref-type="bibr" rid="B68">Tan et al. (2013)</xref> further defined their dataset by comparing the genes found in the RISC complex with genes that were found to be upregulated in <italic>miR-128</italic> knockout D1 neurons, resulting in a smaller pool of 154 genes. The majority of the genes within this smaller dataset were enriched in the ERK pathway and other pathways relevant to neuronal function like ion transport, voltage-gated ion channel activity and <italic>G</italic>-protein signaling.</p>
<p>Next, we compared the two datasets from TargetScan (801 genes) and <xref ref-type="bibr" rid="B68">Tan et al. (2013</xref>; 1061 genes) which indicated 214 genes were commonly shared (Data TS &amp; T, <bold>Figure <xref ref-type="fig" rid="F1">1A</xref></bold>, Supplementary Table <xref ref-type="supplementary-material" rid="SM1">S1</xref>).</p>
<p>In addition, we performed a literature review for genes that had been empirically identified as direct targets of <italic>miR-128</italic>. From this, 50 genes (Dataset P) were identified (source: PubMed, Scopus May 2015; Supplementary Table <xref ref-type="supplementary-material" rid="SM2">S2</xref>). Out of these 50 genes, 9 genes (<italic>Arpp21</italic>, <italic>Bmi1</italic>, <italic>Csf1</italic>, <italic>Irs1</italic>, <italic>Casc3</italic>, <italic>Mapk14</italic>, <italic>Rxra</italic>, <italic>Snap25</italic>, and <italic>Sp1</italic>) were also shared by Dataset TS &amp; T (<bold>Figure <xref ref-type="fig" rid="F1">1A</xref></bold>), meaning that these nine genes were identified by <xref ref-type="bibr" rid="B68">Tan et al. (2013)</xref> TargetScan and are confirmed targets of <italic>miR-128</italic> (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Neuropsychiatric association of several <italic>miR-128</italic> target genes from the combined datasets TS, T, and P.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Gene</th>
<th align="left" colspan="1" rowspan="1" valign="top">Function/association with neuropsychiatric phenotypes</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Bmi1 polycomb ring finger oncogene (<italic>Bmi1</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promotes cell proliferation and regulates endogenous antioxidant defense pathway (<xref ref-type="bibr" rid="B40">Leung et al., 2004</xref>; <xref ref-type="bibr" rid="B80">Zencak et al., 2005</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>Bmi1</italic>-knockout mice exhibit epileptic-like seizures and progressive ataxia (<xref ref-type="bibr" rid="B8">Cao et al., 2012</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Colony stimulating factor 1 (<italic>Csf1</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mediates growth and differentiation of macrophage. Target of p53 tumor suppressor gene (<xref ref-type="bibr" rid="B3">Azzam et al., 2013</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Plasma <italic>Csf1</italic> level increased in Alzheimer’s disease patients (<xref ref-type="bibr" rid="B37">Laske et al., 2010</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Insulin receptor substrate 1 (<italic>Irs1</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates insulin signaling (<xref ref-type="bibr" rid="B81">Zheng and Quirion, 2004</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Downregulated in hippocampus of an Alzheimer’s disease model (<xref ref-type="bibr" rid="B24">Han et al., 2012</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Retinoid × receptor, alpha (<italic>Rxra</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates cholesterol metabolism (<xref ref-type="bibr" rid="B21">Gentili et al., 2005</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">The rs3132293 variant is associated with a higher risk of Alzheimer’s disease (<xref ref-type="bibr" rid="B33">Kolsch et al., 2009</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">High deletion rate of <italic>RXRA</italic> in schizophrenic patients (<xref ref-type="bibr" rid="B38">Lee et al., 2010</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptosomal associated protein, 25 kDa (<italic>Snap25</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptosome-associated protein (<xref ref-type="bibr" rid="B53">Oyler et al., 1989</xref>). Involved in docking and fusion of synaptic vesicles (<xref ref-type="bibr" rid="B66">Sollner et al., 1993</xref>; <xref ref-type="bibr" rid="B77">Xu et al., 2013</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Association with attention-deficit/ hyperactivity disorder (<xref ref-type="bibr" rid="B17">Faraone et al., 2005</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Downregulated in hippocampi of schizophrenic patients (<xref ref-type="bibr" rid="B71">Thompson et al., 2003</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sp1 transcription factor (<italic>Sp1</italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">A transcription factor (<xref ref-type="bibr" rid="B15">Dynan and Tjian, 1983</xref>). Expressed mainly in glia (<xref ref-type="bibr" rid="B44">Mao et al., 2009</xref>, <xref ref-type="bibr" rid="B45">2014</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Upregulates the expression of Akt-induced vascular endothelial growth factor (<xref ref-type="bibr" rid="B58">Pore et al., 2004</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulates the expression of Huntingtin (<italic>HTT</italic>) gene (<xref ref-type="bibr" rid="B73">Wang et al., 2012</xref>).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
</tr>
</tbody>
</table>
</table-wrap>
<p>We noticed that some of the published <italic>miR-128</italic> target genes were not identified by Tan’s study, such as Bcl-2 associated X protein (<italic>Bax</italic>; <xref ref-type="bibr" rid="B1">Adlakha and Saini, 2011</xref>), cAMP responsive element binding protein 1 (<italic>Creb1</italic>; <xref ref-type="bibr" rid="B43">Lin et al., 2011</xref>), Doublecortin (<italic>Dcx</italic>; <xref ref-type="bibr" rid="B16">Evangelisti et al., 2009</xref>) (<italic>Egfr</italic>; <xref ref-type="bibr" rid="B74">Weiss et al., 2008</xref>; <xref ref-type="bibr" rid="B54">Papagiannakopoulos et al., 2012</xref>), Neurofibromin 1 (<italic>Nf1</italic>; <xref ref-type="bibr" rid="B55">Paschou and Doxakis, 2012</xref>), Reelin (<italic>Reln</italic>; <xref ref-type="bibr" rid="B16">Evangelisti et al., 2009</xref>; <xref ref-type="bibr" rid="B43">Lin et al., 2011</xref>), and Wingless-related MMTV integration site 3a (<italic>Wnt3a</italic>; <xref ref-type="bibr" rid="B76">Wu et al., 2014</xref>). This may indicate several issues when determining target genes using different approaches. In particular, the target genes in <xref ref-type="bibr" rid="B68">Tan et al. (2013)</xref> were determined using the HITS-CLIP method with adult <italic>Camk2a</italic>-neurons and this method may have limited target gene identification to only genes that were expressed in those cells at that particular time. The rationale behind using these cells is justified in the <xref ref-type="bibr" rid="B68">Tan et al. (2013)</xref> study as they were most interested in genes that were affected by the <italic>miR-128</italic> deletion in dopamine responsive neurons. However, this does impose a limitation to their target gene list. TargetScan and other miRNA database prediction software are likely to produce slightly different lists as these analyses are based on bioinformatics prediction software, irrespective of the tissue expression.</p>
<p>Some of the genes missing from the <xref ref-type="bibr" rid="B68">Tan et al. (2013)</xref> dataset included genes that are known to be expressed in the brain at the time points used in the <xref ref-type="bibr" rid="B68">Tan et al. (2013)</xref> study. For example, <italic>Dcx</italic> and <italic>Reln</italic> are known <italic>miR-128</italic> targets and they are expressed in adult mouse forebrains (<xref ref-type="bibr" rid="B16">Evangelisti et al., 2009</xref>) including the striatum (<xref ref-type="bibr" rid="B20">Gates et al., 2006</xref>; <xref ref-type="bibr" rid="B28">Kang et al., 2011</xref>). Furthermore, knockout <italic>Dcx</italic> and <italic>Reln</italic> mice also exhibit anxiety and epileptic phenotypes, which are similar to the <italic>miR-128</italic> knockout mice in the <xref ref-type="bibr" rid="B68">Tan et al. (2013)</xref> study. It is unclear why these genes were not identified. It may be that the level of expression of these particular genes was too low to be detected or the <italic>miR-128</italic> regulation is specific to certain time points not included in the <xref ref-type="bibr" rid="B68">Tan et al. (2013)</xref> study.</p>
<p>When we grouped together the dataset shared exclusively between TS &amp; T (205 genes) and included the dataset of published target genes (Dataset P, 50 genes), the number of candidate genes was 255 (Data TS and T &amp; P). We then narrowed down the list by screening for associations with mental and behavioral disorders (as outlined by the International Statistical Classification of Diseases and Related Health Problems 10th Revision, ICD-10 version: 2010), first through the Genecard database (<ext-link ext-link-type="uri" xlink:href="http://www.genecards.org/">http://www.genecards.org/</ext-link>; <xref ref-type="bibr" rid="B67">Stelzer et al., 2011</xref>, an integrated human genes compendium), where 95 genes showed an association. The rest of the genes were subjected to systemic review on PubMed. From both of these two approaches, 109 genes out of the 255 genes (42.7%) were found to have neuropsychiatric associations (Data NP; Supplementary Figure <xref ref-type="supplementary-material" rid="SM6">S1</xref> and Table <xref ref-type="supplementary-material" rid="SM3">S3</xref>). We then applied this list through the Database of Annotation, Visualization, and Integrated Discovery (DAVID) bioinformatics tool (version 6.7; <xref ref-type="bibr" rid="B26">Huang et al., 2009</xref>) to determine whether any functional clusters were enriched.</p>
<p>Analysis by DAVID yielded 29 functional clusters (under highest classification stringency), the Top 10 of which are shown in <bold>Figure <xref ref-type="fig" rid="F1">1B</xref></bold> (the entire list can be found in Supplementary Table <xref ref-type="supplementary-material" rid="SM4">S4</xref>). These functional clusters indicated involvement in nucleotide binding, protein kinase activity, apoptosis, neuronal development, ion homeostasis, and maintaining cytoplasmic membrane-bound vesicles (<bold>Figure <xref ref-type="fig" rid="F1">1B</xref></bold>).</p>
<p>The KEGG annotation tool in DAVID further identified 20 shared biological pathways (<bold>Figure <xref ref-type="fig" rid="F1">1C</xref></bold>; Supplementary Table <xref ref-type="supplementary-material" rid="SM5">S5</xref>). We found several relevant neuropsychiatric pathways, such as the MAPK signaling pathway, neurotrophin signaling and regulation of the actin cytoskeleton which is related to neuronal morphology. The involvement of the MAPK pathway has been demonstrated by <xref ref-type="bibr" rid="B68">Tan et al. (2013)</xref>, where they found that many genes in their target dataset were associated with the ERK pathway, and <italic>Erk2</italic> elevation was seen in the <italic>miR-128</italic> knockout mice. Cancer-associated pathways accounted for a large fraction of the genes identified (for example, in colorectal, lung, and prostate cancers), (<bold>Figure <xref ref-type="fig" rid="F1">1C</xref></bold>). The role of <italic>miR-128</italic> and its target genes in cancer has been discussed in an excellent review (<xref ref-type="bibr" rid="B42">Li et al., 2013</xref>) and we will not discuss this aspect further.</p>
</sec>
<sec>
<title>Candidate <italic>miR-128</italic> Target Genes With Relevant Associations To Neuropsychiatric Phenotypes</title>
<p>In this section, we aim to review some of the genes that have been identified through the comparative analysis of the different datasets and are relevant to neuropsychiatric disorders. Due to space limitations, we are unable to review all the genes but the ones selected here are those that are involved in the MAPK signaling pathway, neuronal development, and synaptic plasticity.</p>
<sec>
<title>Mapk10/JNK3</title>
<p>Mitogen-activated protein kinase 10 (<italic>Mapk10</italic>, or also known as c-Jun N-terminal kinase, <italic>JNK3</italic>), a known effector of Rho-GTPase kinase, is enriched in the nervous system (<xref ref-type="bibr" rid="B48">Mohit et al., 1995</xref>). Although the <italic>Mapk10</italic> gene was shown to associate with the <italic>miR-128</italic> binding complex in the Tan study, the expression of <italic>Mapk10</italic> is not upregulated in <italic>miR-128</italic>-deficient D1 neurons (<xref ref-type="bibr" rid="B68">Tan et al., 2013</xref>). Whilst there was no change in the D1 neurons, <italic>MAPK10</italic> is still an important gene to consider as a <italic>miR-128</italic> target and in a neuronal context due to its role in phosphorylating and binding PSD-95 in dendritic spines (<xref ref-type="bibr" rid="B36">Kunde et al., 2013</xref>). In addition, patients with chromosomal translocations at the <italic>MAPK10</italic> locus present with epileptic seizures, motor and cognitive delays (<xref ref-type="bibr" rid="B64">Shoichet et al., 2006</xref>; <xref ref-type="bibr" rid="B36">Kunde et al., 2013</xref>) and a recent behavioral study by <xref ref-type="bibr" rid="B62">Reinecke et al. (2013)</xref> reported that <italic>Mapk10</italic> knockout mice showed signs of anxiety as they were less active and did not exhibit normal navigational behavior during the Morris water maze task. The authors hypothesize the behavior could be due to impaired neuronal plasticity as MAPK/JNKs are involved in synaptic development (<xref ref-type="bibr" rid="B69">Tararuk et al., 2006</xref>).</p>
</sec>
<sec>
<title>Arpp21/Rcs</title>
<p><italic>ARPP21</italic>, a cytosolic neuronal phosphoprotein, is highly expressed in the mammalian central nervous system especially within the basal ganglia (<xref ref-type="bibr" rid="B72">Walaas et al., 1983</xref>; <xref ref-type="bibr" rid="B51">Ouimet et al., 1989</xref>). <italic>Arpp21</italic> functions as a calmodulin (CaM) signaling regulator (and it is also known as Regulator of calmodulin signaling, <italic>Rcs</italic>) (<xref ref-type="bibr" rid="B61">Rakhilin et al., 2004</xref>). CaM plays an important role at the synapse as it regulates the release of neurotransmitters from the presynaptic terminal (<xref ref-type="bibr" rid="B2">Ando et al., 2013</xref>). Phosphorylation of serine residue 55 (Ser55) by protein kinase A (PKA) in <italic>Arpp21</italic> also leads to an increased binding to CaM, which inhibits the CaM activity, and in turn affects calcineurin, a CaM-dependent phosphatase 2B, and CaM kinase I (CaMKI) activities (<xref ref-type="bibr" rid="B75">Williams et al., 1989</xref>; <xref ref-type="bibr" rid="B61">Rakhilin et al., 2004</xref>). PKA phosphorylates <italic>Arpp21</italic> at the Ser55 residue and this phosphorylation can be modulated by D1 and D2 receptor agonists whereby, there was increased phosphorylation upon D1 receptor agonist treatment, but decreased phosphorylation when exposed to D2 receptor agonists (<xref ref-type="bibr" rid="B9">Caporaso et al., 2000</xref>). In addition, this phosphorylation is sensitive to methamphetamine and cocaine (<xref ref-type="bibr" rid="B9">Caporaso et al., 2000</xref>), which is not surprising, given its expression within the limbic system. Taken together, data from several studies (<xref ref-type="bibr" rid="B47">Megraw et al., 2010</xref>; <xref ref-type="bibr" rid="B13">Davis et al., 2012</xref>; <xref ref-type="bibr" rid="B68">Tan et al., 2013</xref>) and its role in the CAM kinase pathway strongly indicates a potential role for <italic>Arpp21</italic> in regulating the development of neuropsychiatric symptoms.</p>
<p>There are six out of seven genes (nine genes in total excluding <italic>Mapk19</italic> and <italic>Arpp21</italic>; <bold>Figure <xref ref-type="fig" rid="F1">1A</xref></bold>) present in Dataset TS, T, and P that have been reported to be associated with neurologically relevant functions (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>). For the seventh gene, cancer susceptibility candidate 3 (<italic>Casc3</italic>, or known as <italic>Mln51</italic>), most reports link this gene to non-sense-mediated mRNA decay (<xref ref-type="bibr" rid="B10">Chang et al., 2007</xref>) and the exon junction complex (<xref ref-type="bibr" rid="B11">Chazal et al., 2013</xref>) but there are no reports so far of any association with neurological/neuropsychiatric functions.</p>
<p>In addition to the candidate genes (which were shared by all datasets) reviewed above and in <bold>Table <xref ref-type="table" rid="T1">1</xref></bold>, we also reviewed other genes with highly suggestive neuropsychiatric associations, which were identified either through the TargetScan prediction and/or through literature reviews.</p>
</sec>
<sec>
<title>Reln</title>
<p>Reln is an extracellular glycoprotein secreted by Cajal-Retzius cells during prenatal development (<xref ref-type="bibr" rid="B14">Del Rio et al., 1997</xref>) and has an important role in neuronal migration (<xref ref-type="bibr" rid="B19">Frotscher et al., 2009</xref>). <italic>Reln</italic> is a direct target of <italic>miR-128</italic> (<xref ref-type="bibr" rid="B16">Evangelisti et al., 2009</xref>; <xref ref-type="bibr" rid="B43">Lin et al., 2011</xref>).</p>
<p><italic>RELN</italic> expression is downregulated in schizophrenia, bipolar disorders (<xref ref-type="bibr" rid="B23">Guidotti et al., 2000</xref>), autism (<xref ref-type="bibr" rid="B18">Fatemi et al., 2005</xref>), and Alzheimer’s disease (<xref ref-type="bibr" rid="B25">Herring et al., 2012</xref>). Polymorphisms in <italic>RELN</italic> associate with the risk of developing schizophrenia in the Han Chinese female population (<xref ref-type="bibr" rid="B35">Kuang et al., 2011</xref>), but this has not been corroborated by <xref ref-type="bibr" rid="B52">Ovadia and Shifman (2011)</xref>. Rather, what they found was that the shorter isoform of <italic>RELN</italic> was significantly reduced in bipolar samples and an allelic imbalance of <italic>RELN</italic> expression in schizophrenia samples. The authors speculate that epigenetic factors or genetic imprinting may be responsible for the abnormal RELN function in these disorders.</p>
<p><italic>Reln</italic> homozygous mutant mice have abnormal brain development and an enhanced rate of seizures (<xref ref-type="bibr" rid="B56">Patrylo et al., 2006</xref>; <xref ref-type="bibr" rid="B60">Qiu et al., 2006</xref>). In addition, <xref ref-type="bibr" rid="B60">Qiu et al. (2006)</xref> observed a reduction in freezing behavior (animal stops moving due to fear) which is associated with a defect in associative learning but other anxiety-like behaviors were normal. Similarly, no stress- and anxiety-like behaviors were found in <italic>Reln</italic> heterozygous mice (<xref ref-type="bibr" rid="B70">Teixeira et al., 2011</xref>), but they found that mice with <italic>Reln</italic> overexpressed were less susceptible to depressive-like behaviors and were resistant to chronic cocaine stimulation.</p>
<p>An interesting study has shown that cleavage at a particular site on the RELN protein (known as N-t), can sustain RELN activity beyond the normal range of the wildtype protein in an <italic>in vitro</italic> model (<xref ref-type="bibr" rid="B31">Koie et al., 2014</xref>), which may point to a potential therapeutic target for certain neuropsychiatric disorders.</p>
</sec>
<sec>
<title>Dcx</title>
<p>DCX is a microtubule associated protein which binds to microtubules to enable neuronal migration (<xref ref-type="bibr" rid="B32">Koizumi et al., 2006</xref>; <xref ref-type="bibr" rid="B49">Moores et al., 2006</xref>). DCX is also involved in the dynamic development of dendrites through regulating their length, branching point and complexity of the dendrites (<xref ref-type="bibr" rid="B12">Cohen et al., 2008</xref>). In addition, DCX regulates the distribution of neurofascin, a cell surface adhesion molecule at the outer surface of the cell in a microtubule-independent manner (<xref ref-type="bibr" rid="B78">Yap et al., 2012</xref>), which in turn, regulate axonal outgrowth and the formation of GABAergic synapses. <italic>DCX</italic> mutations are commonly associated with lissencephaly, smooth brain disorder, a neuronal migration disorder which then leads to epilepsy and mental retardation (<xref ref-type="bibr" rid="B27">Jang et al., 2013</xref>).</p>
<p><italic>MiR-128</italic> inhibits the expression of <italic>Dcx</italic> by directly binding on its 3′UTR region and inhibition of <italic>miR-128</italic> successfully restores the expression of <italic>Dcx</italic> (<xref ref-type="bibr" rid="B16">Evangelisti et al., 2009</xref>). <italic>Dcx</italic> mutant mice exhibit a range of abnormal behaviors such as hyperactivity, spontaneous seizures, impaired social interaction, and decreased aggression (<xref ref-type="bibr" rid="B50">Nosten-Bertrand et al., 2008</xref>; <xref ref-type="bibr" rid="B22">Germain et al., 2013</xref>). Disorganized hippocampal CA3 regions have been observed (<xref ref-type="bibr" rid="B50">Nosten-Bertrand et al., 2008</xref>) and may account for the various behaviors, but a recent study indicated that the typical hippocampal-dependent behaviors such as spatial memory were not impaired in <italic>Dcx</italic> knockout mice (<xref ref-type="bibr" rid="B22">Germain et al., 2013</xref>).</p>
</sec>
</sec>
<sec>
<title>Conclusion</title>
<p>In this article, we sought to evaluate the potential role of <italic>miR-128</italic> target genes in neuropsychiatric disorders. We noticed that out of the 801 genes predicted to be targets of <italic>miR-128</italic> by TargetScan, only a small number of genes have been empirically proven to be regulated by this miRNA. This indicates a large void of knowledge of which genes are true targets of <italic>miR-128</italic>, and more research is needed to construct a broader picture of the pathways regulated by <italic>miR-128.</italic></p>
<p>Based on a systematic review and analysis of predicted and current empirically determined targets of <italic>miR-128</italic>, we found that <italic>miR-128</italic> regulates many pathways within the cell, including pathways involved in cancer or neuronal maturation. With respect to neuropsychiatric phenotypes, we found an association with many <italic>miR-128</italic> target genes. As many of these have well characterized functions, we postulate that therapeutic targets can be directed toward these known pathways and the central role <italic>miR-128</italic> plays in these pathways may indicate a potential role as a biomarker for selected neuropsychiatric disorders.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>We would like to thank members of the lab for their helpful comments on the manuscript and the Ministry of Higher Education-High Impact Research (MOHE-HIR-E29) and University of Malaya (RG399/12HTM) grants.</p>
</ack>
<sec sec-type="supplementary material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fncel.2015.00465">http://journal.frontiersin.org/article/10.3389/fncel.2015.00465</ext-link></p>
<supplementary-material content-type="local-data" id="SM1">
<media xlink:href="Table_1.XLSX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM2">
<media xlink:href="Table_2.XLSX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM3">
<media xlink:href="Table_3.XLSX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM4">
<media xlink:href="Table_4.XLSX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM5">
<media xlink:href="Table_5.XLSX">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="SM6">
<media xlink:href="Image_1.PDF">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adlakha</surname><given-names>Y. K.</given-names></name><name><surname>Saini</surname><given-names>N.</given-names></name></person-group> (<year>2011</year>). <article-title>MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells.</article-title>
<source/><italic>Cell. Mol. Life Sci.</italic>
<volume>68</volume>
<fpage>1415</fpage>–<lpage>1428</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-010-0528-y</pub-id><pub-id pub-id-type="pmid">20924637</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ando</surname><given-names>K.</given-names></name><name><surname>Kudo</surname><given-names>Y.</given-names></name><name><surname>Aoyagi</surname><given-names>K.</given-names></name><name><surname>Ishikawa</surname><given-names>R.</given-names></name><name><surname>Igarashi</surname><given-names>M.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Calmodulin-dependent regulation of neurotransmitter release differs in subsets of neuronal cells.</article-title>
<source/><italic>Brain Res.</italic>
<volume>1535</volume>
<fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2013.08.018</pub-id><pub-id pub-id-type="pmid">23973605</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azzam</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Bell</surname><given-names>D.</given-names></name><name><surname>Murphy</surname><given-names>M. E.</given-names></name></person-group> (<year>2013</year>). <article-title>CSF1 is a novel p53 target gene whose protein product functions in a feed-forward manner to suppress apoptosis and enhance p53-mediated growth arrest.</article-title>
<source/><italic>PLoS ONE</italic>
<volume>8</volume>:<issue>e74297</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0074297</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartel</surname><given-names>D. P.</given-names></name></person-group> (<year>2009</year>). <article-title>MicroRNAs: target recognition and regulatory functions.</article-title>
<source/><italic>Cell</italic>
<volume>136</volume>
<fpage>215</fpage>–<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2009.01.002</pub-id><pub-id pub-id-type="pmid">19167326</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beveridge</surname><given-names>N. J.</given-names></name><name><surname>Gardiner</surname><given-names>E.</given-names></name><name><surname>Carroll</surname><given-names>A. P.</given-names></name><name><surname>Tooney</surname><given-names>P. A.</given-names></name><name><surname>Cairns</surname><given-names>M. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Schizophrenia is associated with an increase in cortical microRNA biogenesis.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>15</volume>
<fpage>1176</fpage>–<lpage>1189</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2009.84</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bocchio-Chiavetto</surname><given-names>L.</given-names></name><name><surname>Maffioletti</surname><given-names>E.</given-names></name><name><surname>Bettinsoli</surname><given-names>P.</given-names></name><name><surname>Giovannini</surname><given-names>C.</given-names></name><name><surname>Bignotti</surname><given-names>S.</given-names></name><name><surname>Tardito</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Blood microRNA changes in depressed patients during antidepressant treatment.</article-title>
<source/><italic>Eur. Neuropsychopharmacol.</italic>
<volume>23</volume>
<fpage>602</fpage>–<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2012.06.013</pub-id><pub-id pub-id-type="pmid">22925464</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruno</surname><given-names>I. G.</given-names></name><name><surname>Karam</surname><given-names>R.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Bhardwaj</surname><given-names>A.</given-names></name><name><surname>Lou</surname><given-names>C. H.</given-names></name><name><surname>Shum</surname><given-names>E. Y.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Identification of a microRNA that activates gene expression by repressing nonsense-mediated RNA decay.</article-title>
<source/><italic>Mol. Cell</italic>
<volume>42</volume>
<fpage>500</fpage>–<lpage>510</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2011.04.018</pub-id><pub-id pub-id-type="pmid">21596314</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>G.</given-names></name><name><surname>Gu</surname><given-names>M.</given-names></name><name><surname>Zhu</surname><given-names>M.</given-names></name><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>Yin</surname><given-names>Y.</given-names></name><name><surname>Marshall</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Bmi-1 absence causes premature brain degeneration.</article-title>
<source/><italic>PLoS ONE</italic>
<volume>7</volume>:<issue>e32015</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0032015</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caporaso</surname><given-names>G. L.</given-names></name><name><surname>Bibb</surname><given-names>J. A.</given-names></name><name><surname>Snyder</surname><given-names>G. L.</given-names></name><name><surname>Valle</surname><given-names>C.</given-names></name><name><surname>Rakhilin</surname><given-names>S.</given-names></name><name><surname>Fienberg</surname><given-names>A. A.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>39</volume>
<fpage>1637</fpage>–<lpage>1644</lpage>. <pub-id pub-id-type="doi">10.1016/S0028-3908(99)00230-0</pub-id><pub-id pub-id-type="pmid">10854908</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>Y. F.</given-names></name><name><surname>Imam</surname><given-names>J. S.</given-names></name><name><surname>Wilkinson</surname><given-names>M. F.</given-names></name></person-group> (<year>2007</year>). <article-title>The nonsense-mediated decay RNA surveillance pathway.</article-title>
<source/><italic>Annu. Rev. Biochem.</italic>
<volume>76</volume>
<fpage>51</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.biochem.76.050106.093909</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chazal</surname><given-names>P. E.</given-names></name><name><surname>Daguenet</surname><given-names>E.</given-names></name><name><surname>Wendling</surname><given-names>C.</given-names></name><name><surname>Ulryck</surname><given-names>N.</given-names></name><name><surname>Tomasetto</surname><given-names>C.</given-names></name><name><surname>Sargueil</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>EJC core component MLN51 interacts with eIF3 and activates translation.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>110</volume>
<fpage>5903</fpage>–<lpage>5908</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1218732110</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>D.</given-names></name><name><surname>Segal</surname><given-names>M.</given-names></name><name><surname>Reiner</surname><given-names>O.</given-names></name></person-group> (<year>2008</year>). <article-title>Doublecortin supports the development of dendritic arbors in primary hippocampal neurons.</article-title>
<source/><italic>Dev. Neurosci.</italic>
<volume>30</volume>
<fpage>187</fpage>–<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1159/000109862</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>M. M.</given-names></name><name><surname>Olausson</surname><given-names>P.</given-names></name><name><surname>Greengard</surname><given-names>P.</given-names></name><name><surname>Taylor</surname><given-names>J. R.</given-names></name><name><surname>Nairn</surname><given-names>A. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Regulator of calmodulin signaling knockout mice display anxiety-like behavior and motivational deficits.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>35</volume>
<fpage>300</fpage>–<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2011.07956.x</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Rio</surname><given-names>J. A.</given-names></name><name><surname>Heimrich</surname><given-names>B.</given-names></name><name><surname>Borrell</surname><given-names>V.</given-names></name><name><surname>Forster</surname><given-names>E.</given-names></name><name><surname>Drakew</surname><given-names>A.</given-names></name><name><surname>Alcantara</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>1997</year>). <article-title>A role for Cajal-Retzius cells and reelin in the development of hippocampal connections.</article-title>
<source/><italic>Nature</italic>
<volume>385</volume>
<fpage>70</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1038/385070a0</pub-id><pub-id pub-id-type="pmid">8985248</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dynan</surname><given-names>W. S.</given-names></name><name><surname>Tjian</surname><given-names>R.</given-names></name></person-group> (<year>1983</year>). <article-title>The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter.</article-title>
<source/><italic>Cell</italic>
<volume>35</volume>
<fpage>79</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(83)90210-6</pub-id><pub-id pub-id-type="pmid">6313230</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evangelisti</surname><given-names>C.</given-names></name><name><surname>Florian</surname><given-names>M. C.</given-names></name><name><surname>Massimi</surname><given-names>I.</given-names></name><name><surname>Dominici</surname><given-names>C.</given-names></name><name><surname>Giannini</surname><given-names>G.</given-names></name><name><surname>Galardi</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness.</article-title>
<source/><italic>FASEB J.</italic>
<volume>23</volume>
<fpage>4276</fpage>–<lpage>4287</lpage>. <pub-id pub-id-type="doi">10.1096/fj.09-134965</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faraone</surname><given-names>S. V.</given-names></name><name><surname>Perlis</surname><given-names>R. H.</given-names></name><name><surname>Doyle</surname><given-names>A. E.</given-names></name><name><surname>Smoller</surname><given-names>J. W.</given-names></name><name><surname>Goralnick</surname><given-names>J. J.</given-names></name><name><surname>Holmgren</surname><given-names>M. A.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Molecular genetics of attention-deficit/hyperactivity disorder.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>57</volume>
<fpage>1313</fpage>–<lpage>1323</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2004.11.024</pub-id><pub-id pub-id-type="pmid">15950004</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fatemi</surname><given-names>S. H.</given-names></name><name><surname>Snow</surname><given-names>A. V.</given-names></name><name><surname>Stary</surname><given-names>J. M.</given-names></name><name><surname>Araghi-Niknam</surname><given-names>M.</given-names></name><name><surname>Reutiman</surname><given-names>T. J.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Reelin signaling is impaired in autism.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>57</volume>
<fpage>777</fpage>–<lpage>787</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2004.12.018</pub-id><pub-id pub-id-type="pmid">15820235</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frotscher</surname><given-names>M.</given-names></name><name><surname>Chai</surname><given-names>X.</given-names></name><name><surname>Bock</surname><given-names>H. H.</given-names></name><name><surname>Haas</surname><given-names>C. A.</given-names></name><name><surname>Forster</surname><given-names>E.</given-names></name><name><surname>Zhao</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Role of Reelin in the development and maintenance of cortical lamination.</article-title>
<source/><italic>J. Neural Transm.</italic>
<volume>116</volume>
<fpage>1451</fpage>–<lpage>1455</lpage>. <pub-id pub-id-type="doi">10.1007/s00702-009-0228-7</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gates</surname><given-names>M. A.</given-names></name><name><surname>Torres</surname><given-names>E. M.</given-names></name><name><surname>White</surname><given-names>A.</given-names></name><name><surname>Fricker-Gates</surname><given-names>R. A.</given-names></name><name><surname>Dunnett</surname><given-names>S. B.</given-names></name></person-group> (<year>2006</year>). <article-title>Re-examining the ontogeny of substantia nigra dopamine neurons.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>23</volume>
<fpage>1384</fpage>–<lpage>1390</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.04637.x</pub-id><pub-id pub-id-type="pmid">16553799</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gentili</surname><given-names>C.</given-names></name><name><surname>Tutolo</surname><given-names>G.</given-names></name><name><surname>Pianezzi</surname><given-names>A.</given-names></name><name><surname>Cancedda</surname><given-names>R.</given-names></name><name><surname>Descalzi Cancedda</surname><given-names>F.</given-names></name></person-group> (<year>2005</year>). <article-title>Cholesterol secretion and homeostasis in chondrocytes: a liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein A1 expression.</article-title>
<source/><italic>Matrix Biol.</italic>
<volume>24</volume>
<fpage>35</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2004.12.003</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Germain</surname><given-names>J.</given-names></name><name><surname>Bruel-Jungerman</surname><given-names>E.</given-names></name><name><surname>Grannec</surname><given-names>G.</given-names></name><name><surname>Denis</surname><given-names>C.</given-names></name><name><surname>Lepousez</surname><given-names>G.</given-names></name><name><surname>Giros</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Doublecortin knockout mice show normal hippocampal-dependent memory despite CA3 lamination defects.</article-title>
<source/><italic>PLoS ONE</italic>
<volume>8</volume>:<issue>e74992</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0074992</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guidotti</surname><given-names>A.</given-names></name><name><surname>Auta</surname><given-names>J.</given-names></name><name><surname>Davis</surname><given-names>J. M.</given-names></name><name><surname>Di-Giorgi-Gerevini</surname><given-names>V.</given-names></name><name><surname>Dwivedi</surname><given-names>Y.</given-names></name><name><surname>Grayson</surname><given-names>D. R.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study.</article-title>
<source/><italic>Arch. Gen. Psychiatry</italic>
<volume>57</volume>
<fpage>1061</fpage>–<lpage>1069</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.57.11.1061</pub-id><pub-id pub-id-type="pmid">11074872</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>X.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Qi</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Changes in insulin-signaling transduction pathway underlie learning/memory deficits in an Alzheimer’s disease rat model.</article-title>
<source/><italic>J. Neural Transm.</italic>
<volume>119</volume>
<fpage>1407</fpage>–<lpage>1416</lpage>. <pub-id pub-id-type="doi">10.1007/s00702-012-0803-1</pub-id><pub-id pub-id-type="pmid">22527777</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herring</surname><given-names>A.</given-names></name><name><surname>Donath</surname><given-names>A.</given-names></name><name><surname>Steiner</surname><given-names>K. M.</given-names></name><name><surname>Widera</surname><given-names>M. P.</given-names></name><name><surname>Hamzehian</surname><given-names>S.</given-names></name><name><surname>Kanakis</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Reelin depletion is an early phenomenon of Alzheimer’s pathology.</article-title>
<source/><italic>J. Alzheimers Dis.</italic>
<volume>30</volume>
<fpage>963</fpage>–<lpage>979</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2012-112069</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>D. W.</given-names></name><name><surname>Sherman</surname><given-names>B. T.</given-names></name><name><surname>Lempicki</surname><given-names>R. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.</article-title>
<source/><italic>Nat. Protoc.</italic>
<volume>4</volume>
<fpage>44</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id><pub-id pub-id-type="pmid">19131956</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>M. A.</given-names></name><name><surname>Woo</surname><given-names>H. I.</given-names></name><name><surname>Kim</surname><given-names>J. W.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Ki</surname><given-names>C. S.</given-names></name></person-group> (<year>2013</year>). <article-title>Identification of DCX gene mutation in lissencephaly spectrum with subcortical band heterotopia using whole exome sequencing.</article-title>
<source/><italic>Pediatr. Neurol.</italic>
<volume>48</volume>
<fpage>411</fpage>–<lpage>414</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2012.12.033</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>H. J.</given-names></name><name><surname>Kawasawa</surname><given-names>Y. I.</given-names></name><name><surname>Cheng</surname><given-names>F.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Spatio-temporal transcriptome of the human brain.</article-title>
<source/><italic>Nature</italic>
<volume>478</volume>
<fpage>483</fpage>–<lpage>489</lpage>. <pub-id pub-id-type="doi">10.1038/nature10523</pub-id><pub-id pub-id-type="pmid">22031440</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karam</surname><given-names>R.</given-names></name><name><surname>Wilkinson</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>A conserved microRNA/NMD regulatory circuit controls gene expression.</article-title>
<source/><italic>RNA Biol.</italic>
<volume>9</volume>
<fpage>22</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.4161/rna.9.1.18010</pub-id><pub-id pub-id-type="pmid">22258150</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Krichevsky</surname><given-names>A.</given-names></name><name><surname>Grad</surname><given-names>Y.</given-names></name><name><surname>Hayes</surname><given-names>G. D.</given-names></name><name><surname>Kosik</surname><given-names>K. S.</given-names></name><name><surname>Church</surname><given-names>G. M.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Identification of many microRNAs that copurify with polyribosomes in mammalian neurons.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>101</volume>
<fpage>360</fpage>–<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.2333854100</pub-id><pub-id pub-id-type="pmid">14691248</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koie</surname><given-names>M.</given-names></name><name><surname>Okumura</surname><given-names>K.</given-names></name><name><surname>Hisanaga</surname><given-names>A.</given-names></name><name><surname>Kamei</surname><given-names>T.</given-names></name><name><surname>Sasaki</surname><given-names>K.</given-names></name><name><surname>Deng</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Cleavage within Reelin repeat 3 regulates the duration and range of the signaling activity of Reelin protein.</article-title>
<source/><italic>J. Biol. Chem.</italic>
<volume>289</volume>
<fpage>12922</fpage>–<lpage>12930</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.536326</pub-id><pub-id pub-id-type="pmid">24644294</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koizumi</surname><given-names>H.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name><name><surname>Gleeson</surname><given-names>J. G.</given-names></name></person-group> (<year>2006</year>). <article-title>Doublecortin-like kinase functions with doublecortin to mediate fiber tract decussation and neuronal migration.</article-title>
<source/><italic>Neuron</italic>
<volume>49</volume>
<fpage>55</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2005.10.040</pub-id><pub-id pub-id-type="pmid">16387639</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolsch</surname><given-names>H.</given-names></name><name><surname>Lutjohann</surname><given-names>D.</given-names></name><name><surname>Jessen</surname><given-names>F.</given-names></name><name><surname>Popp</surname><given-names>J.</given-names></name><name><surname>Hentschel</surname><given-names>F.</given-names></name><name><surname>Kelemen</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>RXRA gene variations influence Alzheimer’s disease risk and cholesterol metabolism.</article-title>
<source/><italic>J. Cell. Mol. Med.</italic>
<volume>13</volume>
<fpage>589</fpage>–<lpage>598</lpage>. <pub-id pub-id-type="doi">10.1111/j.1582-4934.2009.00383.x</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krichevsky</surname><given-names>A. M.</given-names></name><name><surname>King</surname><given-names>K. S.</given-names></name><name><surname>Donahue</surname><given-names>C. P.</given-names></name><name><surname>Khrapko</surname><given-names>K.</given-names></name><name><surname>Kosik</surname><given-names>K. S.</given-names></name></person-group> (<year>2003</year>). <article-title>A microRNA array reveals extensive regulation of microRNAs during brain development.</article-title>
<source/><italic>RNA</italic>
<volume>9</volume>
<fpage>1274</fpage>–<lpage>1281</lpage>. <pub-id pub-id-type="doi">10.1261/rna.5980303</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuang</surname><given-names>W. J.</given-names></name><name><surname>Sun</surname><given-names>R. F.</given-names></name><name><surname>Zhu</surname><given-names>Y. S.</given-names></name><name><surname>Li</surname><given-names>S. B.</given-names></name></person-group> (<year>2011</year>). <article-title>A new single-nucleotide mutation (rs362719) of the reelin (RELN) gene associated with schizophrenia in female Chinese Han.</article-title>
<source/><italic>Genet. Mol. Res.</italic>
<volume>10</volume>
<fpage>1650</fpage>–<lpage>1658</lpage>. <pub-id pub-id-type="doi">10.4238/vol10-3gmr1343</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunde</surname><given-names>S. A.</given-names></name><name><surname>Rademacher</surname><given-names>N.</given-names></name><name><surname>Tzschach</surname><given-names>A.</given-names></name><name><surname>Wiedersberg</surname><given-names>E.</given-names></name><name><surname>Ullmann</surname><given-names>R.</given-names></name><name><surname>Kalscheuer</surname><given-names>V. M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Characterisation of de novo MAPK10/JNK3 truncation mutations associated with cognitive disorders in two unrelated patients.</article-title>
<source/><italic>Hum. Genet.</italic>
<volume>132</volume>
<fpage>461</fpage>–<lpage>471</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-012-1260-5</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laske</surname><given-names>C.</given-names></name><name><surname>Stransky</surname><given-names>E.</given-names></name><name><surname>Hoffmann</surname><given-names>N.</given-names></name><name><surname>Maetzler</surname><given-names>W.</given-names></name><name><surname>Straten</surname><given-names>G.</given-names></name><name><surname>Eschweiler</surname><given-names>G. W.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Macrophage colony-stimulating factor (M-CSF) in plasma and CSF of patients with mild cognitive impairment and Alzheimer’s disease.</article-title>
<source/><italic>Curr. Alzheimer Res.</italic>
<volume>7</volume>
<fpage>409</fpage>–<lpage>414</lpage>. <pub-id pub-id-type="doi">10.2174/156720510791383813</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C. H.</given-names></name><name><surname>Liu</surname><given-names>C. M.</given-names></name><name><surname>Wen</surname><given-names>C. C.</given-names></name><name><surname>Chang</surname><given-names>S. M.</given-names></name><name><surname>Hwu</surname><given-names>H. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Genetic copy number variants in sib pairs both affected with schizophrenia.</article-title>
<source/><italic>J. Biomed. Sci.</italic>
<volume>17</volume>
<issue>2</issue>
<pub-id pub-id-type="doi">10.1186/1423-0127-17-2</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>I.</given-names></name><name><surname>Ajay</surname><given-names>S. S.</given-names></name><name><surname>Yook</surname><given-names>J. I.</given-names></name><name><surname>Kim</surname><given-names>H. S.</given-names></name><name><surname>Hong</surname><given-names>S. H.</given-names></name><name><surname>Kim</surname><given-names>N. H.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites.</article-title>
<source/><italic>Genome Res.</italic>
<volume>19</volume>
<fpage>1175</fpage>–<lpage>1183</lpage>. <pub-id pub-id-type="doi">10.1101/gr.089367.108</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>C.</given-names></name><name><surname>Lingbeek</surname><given-names>M.</given-names></name><name><surname>Shakhova</surname><given-names>O.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Tanger</surname><given-names>E.</given-names></name><name><surname>Saremaslani</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas.</article-title>
<source/><italic>Nature</italic>
<volume>428</volume>
<fpage>337</fpage>–<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1038/nature02385</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>B. P.</given-names></name><name><surname>Burge</surname><given-names>C. B.</given-names></name><name><surname>Bartel</surname><given-names>D. P.</given-names></name></person-group> (<year>2005</year>). <article-title>Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.</article-title>
<source/><italic>Cell</italic>
<volume>120</volume>
<fpage>15</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2004.12.035</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Fu</surname><given-names>W.</given-names></name><name><surname>Wo</surname><given-names>L.</given-names></name><name><surname>Shu</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>miR-128 and its target genes in tumorigenesis and metastasis.</article-title>
<source/><italic>Exp. Cell Res.</italic>
<volume>319</volume>
<fpage>3059</fpage>–<lpage>3064</lpage>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2013.07.031</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Q.</given-names></name><name><surname>Wei</surname><given-names>W.</given-names></name><name><surname>Coelho</surname><given-names>C. M.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Baker-Andresen</surname><given-names>D.</given-names></name><name><surname>Dudley</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>The brain-specific microRNA miR-128b regulates the formation of fear-extinction memory.</article-title>
<source/><italic>Nat. Neurosci.</italic>
<volume>14</volume>
<fpage>1115</fpage>–<lpage>1117</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2891</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>X. R.</given-names></name><name><surname>Moerman-Herzog</surname><given-names>A. M.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Barger</surname><given-names>S. W.</given-names></name></person-group> (<year>2009</year>). <article-title>Unique aspects of transcriptional regulation in neurons–nuances in NFkappaB and Sp1-related factors.</article-title>
<source/><italic>J. Neuroinflammation</italic>
<volume>6</volume>
<issue>16</issue>
<pub-id pub-id-type="doi">10.1186/1742-2094-6-16</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>X.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Serum miR-21 is a diagnostic and prognostic marker of primary central nervous system lymphoma.</article-title>
<source/><italic>Neurol. Sci.</italic>
<volume>35</volume>
<fpage>233</fpage>–<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1007/s10072-013-1491-9</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marangi</surname><given-names>G.</given-names></name><name><surname>Orteschi</surname><given-names>D.</given-names></name><name><surname>Milano</surname><given-names>V.</given-names></name><name><surname>Mancano</surname><given-names>G.</given-names></name><name><surname>Zollino</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Interstitial deletion of 3p22.3<italic>p</italic>22.2 encompassing ARPP21 and CLASP2 is a potential pathogenic factor for a syndromic form of intellectual disability: a co-morbidity model with additional copy number variations in a large family.</article-title>
<source/><italic>Am. J. Med. Genet. A</italic>
<volume>161A</volume>, <fpage>2890</fpage>–<lpage>2893</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.36257</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Megraw</surname><given-names>M.</given-names></name><name><surname>Sethupathy</surname><given-names>P.</given-names></name><name><surname>Gumireddy</surname><given-names>K.</given-names></name><name><surname>Jensen</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>Q.</given-names></name><name><surname>Hatzigeorgiou</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Isoform specific gene auto-regulation via miRNAs: a case study on miR-128b and ARPP-21.</article-title>
<source/><italic>Theor. Chem. Acc.</italic>
<volume>125</volume>
<fpage>593</fpage>–<lpage>598</lpage>. <pub-id pub-id-type="doi">10.1007/s00214-009-0647-4</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohit</surname><given-names>A. A.</given-names></name><name><surname>Martin</surname><given-names>J. H.</given-names></name><name><surname>Miller</surname><given-names>C. A.</given-names></name></person-group> (<year>1995</year>). <article-title>p493F12 kinase: a novel MAP kinase expressed in a subset of neurons in the human nervous system.</article-title>
<source/><italic>Neuron</italic>
<volume>14</volume>
<fpage>67</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(95)90241-4</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moores</surname><given-names>C. A.</given-names></name><name><surname>Perderiset</surname><given-names>M.</given-names></name><name><surname>Kappeler</surname><given-names>C.</given-names></name><name><surname>Kain</surname><given-names>S.</given-names></name><name><surname>Drummond</surname><given-names>D.</given-names></name><name><surname>Perkins</surname><given-names>S. J.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Distinct roles of doublecortin modulating the microtubule cytoskeleton.</article-title>
<source/><italic>EMBO J.</italic>
<volume>25</volume>
<fpage>4448</fpage>–<lpage>4457</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601335</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nosten-Bertrand</surname><given-names>M.</given-names></name><name><surname>Kappeler</surname><given-names>C.</given-names></name><name><surname>Dinocourt</surname><given-names>C.</given-names></name><name><surname>Denis</surname><given-names>C.</given-names></name><name><surname>Germain</surname><given-names>J.</given-names></name></person-group> Phan Dinh,<etal></etal> (<year>2008</year>). <article-title>Epilepsy in Dcx knockout mice associated with discrete lamination defects and enhanced excitability in the hippocampus.</article-title>
<source/><italic>PLoS ONE</italic>
<volume>3</volume>:<issue>e2473</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0002473</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouimet</surname><given-names>C. C.</given-names></name><name><surname>Hemmings</surname><given-names>H. C.</given-names><suffix>Jr.</suffix></name><name><surname>Greengard</surname><given-names>P.</given-names></name></person-group> (<year>1989</year>). <article-title>ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Immunocytochemical localization in rat brain.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>9</volume>
<issue>86</issue><fpage>5</fpage>–<lpage>875</lpage>.</mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ovadia</surname><given-names>G.</given-names></name><name><surname>Shifman</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>The genetic variation of RELN expression in schizophrenia and bipolar disorder.</article-title>
<source/><italic>PLoS ONE</italic>
<volume>6</volume>:<issue>e19955</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0019955</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oyler</surname><given-names>G. A.</given-names></name><name><surname>Higgins</surname><given-names>G. A.</given-names></name><name><surname>Hart</surname><given-names>R. A.</given-names></name><name><surname>Battenberg</surname><given-names>E.</given-names></name><name><surname>Billingsley</surname><given-names>M.</given-names></name><name><surname>Bloom</surname><given-names>F. E.</given-names></name><etal></etal></person-group> (<year>1989</year>). <article-title>The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>109</volume>
<fpage>3039</fpage>–<lpage>3052</lpage>.</mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papagiannakopoulos</surname><given-names>T.</given-names></name><name><surname>Friedmann-Morvinski</surname><given-names>D.</given-names></name><name><surname>Neveu</surname><given-names>P.</given-names></name><name><surname>Dugas</surname><given-names>J. C.</given-names></name><name><surname>Gill</surname><given-names>R. M.</given-names></name><name><surname>Huillard</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases.</article-title>
<source/><italic>Oncogene</italic>
<volume>31</volume>
<fpage>1884</fpage>–<lpage>1895</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2011.380</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paschou</surname><given-names>M.</given-names></name><name><surname>Doxakis</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Neurofibromin 1 is a miRNA target in neurons.</article-title>
<source/><italic>PLoS ONE</italic>
<volume>7</volume>:<issue>e46773</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0046773</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patrylo</surname><given-names>P. R.</given-names></name><name><surname>Browning</surname><given-names>R. A.</given-names></name><name><surname>Cranick</surname><given-names>S.</given-names></name></person-group> (<year>2006</year>). <article-title>Reeler homozygous mice exhibit enhanced susceptibility to epileptiform activity.</article-title>
<source/><italic>Epilepsia</italic>
<volume>47</volume>
<fpage>257</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2006.00417.x</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perkins</surname><given-names>D. O.</given-names></name><name><surname>Jeffries</surname><given-names>C. D.</given-names></name><name><surname>Jarskog</surname><given-names>L. F.</given-names></name><name><surname>Thomson</surname><given-names>J. M.</given-names></name><name><surname>Woods</surname><given-names>K.</given-names></name><name><surname>Newman</surname><given-names>M. A.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder.</article-title>
<source/><italic>Genome Biol.</italic>
<volume>8</volume>
<issue>R27</issue>
<pub-id pub-id-type="doi">10.1186/gb-2007-8-2-r27</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pore</surname><given-names>N.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Shu</surname><given-names>H. K.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Haas-Kogan</surname><given-names>D.</given-names></name><name><surname>Stokoe</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism.</article-title>
<source/><italic>Mol. Biol. Cell</italic>
<volume>15</volume>
<fpage>4841</fpage>–<lpage>4853</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E04-05-0374</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>P.</given-names></name><name><surname>Banerjee</surname><given-names>A.</given-names></name><name><surname>Wu</surname><given-names>Z. S.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Pandey</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Loss of SNAIL regulated miR-128-2 on chromosome 3p22.3 targets multiple stem cell factors to promote transformation of mammary epithelial cells.</article-title>
<source/><italic>Cancer Res.</italic>
<volume>72</volume>
<fpage>6036</fpage>–<lpage>6050</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-12-1507</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>S.</given-names></name><name><surname>Korwek</surname><given-names>K. M.</given-names></name><name><surname>Pratt-Davis</surname><given-names>A. R.</given-names></name><name><surname>Peters</surname><given-names>M.</given-names></name><name><surname>Bergman</surname><given-names>M. Y.</given-names></name><name><surname>Weeber</surname><given-names>E. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Cognitive disruption and altered hippocampus synaptic function in Reelin haploinsufficient mice.</article-title>
<source/><italic>Neurobiol. Learn. Mem.</italic>
<volume>85</volume>
<fpage>228</fpage>–<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1016/j.nlm.2005.11.001</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rakhilin</surname><given-names>S. V.</given-names></name><name><surname>Olson</surname><given-names>P. A.</given-names></name><name><surname>Nishi</surname><given-names>A.</given-names></name><name><surname>Starkova</surname><given-names>N. N.</given-names></name><name><surname>Fienberg</surname><given-names>A. A.</given-names></name><name><surname>Nairn</surname><given-names>A. C.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>A network of control mediated by regulator of calcium/calmodulin-dependent signaling.</article-title>
<source/><italic>Science</italic>
<volume>306</volume>
<fpage>698</fpage>–<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1126/science.1099961</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinecke</surname><given-names>K.</given-names></name><name><surname>Herdegen</surname><given-names>T.</given-names></name><name><surname>Eminel</surname><given-names>S.</given-names></name><name><surname>Aldenhoff</surname><given-names>J. B.</given-names></name><name><surname>Schiffelholz</surname><given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>Knockout of c-Jun N-terminal kinases 1, 2 or 3 isoforms induces behavioural changes.</article-title>
<source/><italic>Behav. Brain Res.</italic>
<volume>245</volume>
<fpage>88</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2013.02.013</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmiedel</surname><given-names>J. M.</given-names></name><name><surname>Klemm</surname><given-names>S. L.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name><name><surname>Sahay</surname><given-names>A.</given-names></name><name><surname>Bluthgen</surname><given-names>N.</given-names></name><name><surname>Marks</surname><given-names>D. S.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Gene expression. MicroRNA control of protein expression noise.</article-title>
<source/><italic>Science</italic>
<volume>348</volume>
<fpage>128</fpage>–<lpage>1132</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaa1738</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoichet</surname><given-names>S. A.</given-names></name><name><surname>Duprez</surname><given-names>L.</given-names></name><name><surname>Hagens</surname><given-names>O.</given-names></name><name><surname>Waetzig</surname><given-names>V.</given-names></name><name><surname>Menzel</surname><given-names>C.</given-names></name><name><surname>Herdegen</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Truncation of the CNS-expressed JNK3 in a patient with a severe developmental epileptic encephalopathy.</article-title>
<source/><italic>Hum. Genet.</italic>
<volume>118</volume>
<fpage>559</fpage>–<lpage>567</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-005-0084-y</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smirnova</surname><given-names>L.</given-names></name><name><surname>Grafe</surname><given-names>A.</given-names></name><name><surname>Seiler</surname><given-names>A.</given-names></name><name><surname>Schumacher</surname><given-names>S.</given-names></name><name><surname>Nitsch</surname><given-names>R.</given-names></name><name><surname>Wulczyn</surname><given-names>F. G.</given-names></name></person-group> (<year>2005</year>). <article-title>Regulation of miRNA expression during neural cell specification.</article-title>
<source/><italic>Eur. J. Neurosci.</italic>
<volume>21</volume>
<fpage>1469</fpage>–<lpage>1477</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2005.03978.x</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sollner</surname><given-names>T.</given-names></name><name><surname>Whiteheart</surname><given-names>S. W.</given-names></name><name><surname>Brunner</surname><given-names>M.</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H.</given-names></name><name><surname>Geromanos</surname><given-names>S.</given-names></name><name><surname>Tempst</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>1993</year>). <article-title>SNAP receptors implicated in vesicle targeting and fusion.</article-title>
<source/><italic>Nature</italic>
<volume>362</volume>
<fpage>318</fpage>–<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1038/362318a0</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stelzer</surname><given-names>G.</given-names></name><name><surname>Dalah</surname><given-names>I.</given-names></name><name><surname>Stein</surname><given-names>T. I.</given-names></name><name><surname>Satanower</surname><given-names>Y.</given-names></name><name><surname>Rosen</surname><given-names>N.</given-names></name><name><surname>Nativ</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>In-silico human genomics with GeneCards.</article-title>
<source/><italic>Hum. Genomics</italic>
<volume>5</volume>
<fpage>709</fpage>–<lpage>717</lpage>. <pub-id pub-id-type="doi">10.1186/1479-7364-5-6-709</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>C. L.</given-names></name><name><surname>Plotkin</surname><given-names>J. L.</given-names></name><name><surname>Veno</surname><given-names>M. T.</given-names></name><name><surname>Von Schimmelmann</surname><given-names>M.</given-names></name><name><surname>Feinberg</surname><given-names>P.</given-names></name><name><surname>Mann</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>MicroRNA-128 governs neuronal excitability and motor behavior in mice.</article-title>
<source/><italic>Science</italic>
<volume>342</volume>
<fpage>1254</fpage>–<lpage>1258</lpage>. <pub-id pub-id-type="doi">10.1126/science.1244193</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tararuk</surname><given-names>T.</given-names></name><name><surname>Ostman</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Bjorkblom</surname><given-names>B.</given-names></name><name><surname>Padzik</surname><given-names>A.</given-names></name><name><surname>Zdrojewska</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length.</article-title>
<source/><italic>J. Cell Biol.</italic>
<volume>173</volume>
<fpage>265</fpage>–<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200511055</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teixeira</surname><given-names>C. M.</given-names></name><name><surname>Martin</surname><given-names>E. D.</given-names></name><name><surname>Sahun</surname><given-names>I.</given-names></name><name><surname>Masachs</surname><given-names>N.</given-names></name><name><surname>Pujadas</surname><given-names>L.</given-names></name><name><surname>Corvelo</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Overexpression of Reelin prevents the manifestation of behavioral phenotypes related to schizophrenia and bipolar disorder.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>36</volume>
<fpage>2395</fpage>–<lpage>2405</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2011.153</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>P. M.</given-names></name><name><surname>Egbufoama</surname><given-names>S.</given-names></name><name><surname>Vawter</surname><given-names>M. P.</given-names></name></person-group> (<year>2003</year>). <article-title>SNAP-25 reduction in the hippocampus of patients with schizophrenia.</article-title>
<source/><italic>Prog. Neuropsychopharmacol. Biol. Psychiatry</italic>
<volume>27</volume>
<fpage>411</fpage>–<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1016/S0278-5846(03)00027-7</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walaas</surname><given-names>S. I.</given-names></name><name><surname>Nairn</surname><given-names>A. C.</given-names></name><name><surname>Greengard</surname><given-names>P.</given-names></name></person-group> (<year>1983</year>). <article-title>Regional distribution of calcium– and cyclic adenosine 3’:5’-monophosphate-regulated protein phosphorylation systems in mammalian brain. II. Soluble systems.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>3</volume>
<fpage>302</fpage>–<lpage>311</lpage>.</mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Luo</surname><given-names>Y.</given-names></name><name><surname>Ly</surname><given-names>P. T.</given-names></name><name><surname>Cai</surname><given-names>F.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>Zou</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Sp1 regulates human huntingtin gene expression.</article-title>
<source/><italic>J. Mol. Neurosci.</italic>
<volume>47</volume>
<fpage>311</fpage>–<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-012-9739-z</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>G. J.</given-names></name><name><surname>Bemis</surname><given-names>L. T.</given-names></name><name><surname>Nakajima</surname><given-names>E.</given-names></name><name><surname>Sugita</surname><given-names>M.</given-names></name><name><surname>Birks</surname><given-names>D. K.</given-names></name><name><surname>Robinson</surname><given-names>W. A.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines.</article-title>
<source/><italic>Ann. Oncol.</italic>
<volume>19</volume>
<fpage>1053</fpage>–<lpage>1059</lpage>. <pub-id pub-id-type="doi">10.1093/annonc/mdn006</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>K. R.</given-names></name><name><surname>Hemmings</surname><given-names>H. C.</given-names><suffix>Jr.</suffix></name><name><surname>Lopresti</surname><given-names>M. B.</given-names></name><name><surname>Greengard</surname><given-names>P.</given-names></name></person-group> (<year>1989</year>). <article-title>ARPP-refvol21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Amino acid sequence of ARPP-21B from bovine caudate nucleus.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>9</volume>
<fpage>3631</fpage>–<lpage>3637</lpage>.</mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>R.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Zang</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Du</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>MicroRNA-128 regulates the differentiation of rat bone mesenchymal stem cells into neuron-like cells by Wnt signaling.</article-title>
<source/><italic>Mol. Cell. Biochem.</italic>
<volume>387</volume>
<fpage>151</fpage>–<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1007/s11010-013-1880-7</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Xue</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>X. S.</given-names></name><name><surname>Chiang</surname><given-names>H. C.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>SNARE proteins synaptobrevin, SNAP-25, and syntaxin are involvedin rapid and slow endocytosis at synapses.</article-title>
<source/><italic>Cell Rep.</italic>
<volume>3</volume>
<fpage>1414</fpage>–<lpage>1421</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2013.03.010</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yap</surname><given-names>C. C.</given-names></name><name><surname>Vakulenko</surname><given-names>M.</given-names></name><name><surname>Kruczek</surname><given-names>K.</given-names></name><name><surname>Motamedi</surname><given-names>B.</given-names></name><name><surname>Digilio</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>J. S.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Doublecortin (DCX) mediates endocytosis of neurofascin independently of microtubule binding.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>32</volume>
<fpage>7439</fpage>–<lpage>7453</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5318-11.2012</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zare</surname><given-names>M.</given-names></name><name><surname>Soleimani</surname><given-names>M.</given-names></name><name><surname>Akbarzadeh</surname><given-names>A.</given-names></name><name><surname>Bakhshandeh</surname><given-names>B.</given-names></name><name><surname>Aghaee-Bakhtiari</surname><given-names>S. H.</given-names></name><name><surname>Zarghami</surname><given-names>N.</given-names></name></person-group> (<year>2015</year>). <article-title>A novel protocol to differentiate induced pluripotent stem cells by neuronal microRNAs to provide a suitable cellular model.</article-title>
<source/><italic>Chem. Biol. Drug Des.</italic>
<volume>86</volume>
<fpage>232</fpage>–<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1111/cbdd.12485</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zencak</surname><given-names>D.</given-names></name><name><surname>Lingbeek</surname><given-names>M.</given-names></name><name><surname>Kostic</surname><given-names>C.</given-names></name><name><surname>Tekaya</surname><given-names>M.</given-names></name><name><surname>Tanger</surname><given-names>E.</given-names></name><name><surname>Hornfeld</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Bmi1 loss produces an increase in astroglial cells and a decrease in neural stem cell population and proliferation.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>25</volume>
<fpage>5774</fpage>–<lpage>5783</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3452-04.2005</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>W. H.</given-names></name><name><surname>Quirion</surname><given-names>R.</given-names></name></person-group> (<year>2004</year>). <article-title>Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival.</article-title>
<source/><italic>J. Neurochem.</italic>
<volume>89</volume>
<fpage>844</fpage>–<lpage>852</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.02350.x</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>